NDC 50090-0339

ERY-TAB

Erythromycin

ERY-TAB is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Erythromycin.

Product ID50090-0339_b5f23ae8-c8d5-47b8-bca4-7001faedaea3
NDC50090-0339
Product TypeHuman Prescription Drug
Proprietary NameERY-TAB
Generic NameErythromycin
Dosage FormTablet, Delayed Release
Route of AdministrationORAL
Marketing Start Date2011-04-18
Marketing CategoryANDA / ANDA
Application NumberANDA062298
Labeler NameA-S Medication Solutions
Substance NameERYTHROMYCIN
Active Ingredient Strength333 mg/1
Pharm ClassesDecreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 50090-0339-0

30 TABLET, DELAYED RELEASE in 1 BOTTLE (50090-0339-0)
Marketing Start Date2016-06-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50090-0339-3 [50090033903]

ERY-TAB TABLET, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA062298
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-06-29
Marketing End Date2017-02-28

NDC 50090-0339-0 [50090033900]

ERY-TAB TABLET, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA062298
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-06-29
Marketing End Date2018-11-30

Drug Details

Active Ingredients

IngredientStrength
ERYTHROMYCIN333 mg/1

OpenFDA Data

SPL SET ID:ff20121d-63cb-4248-9f7d-43607e255852
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 206080
  • 310157
  • 315090
  • 206078

    • Pharmacological Class

    • Decreased Sebaceous Gland Activity [PE]
    • Macrolide [EPC]
    • Macrolide Antimicrobial [EPC]
    • Macrolides [CS]

    NDC Crossover Matching brand name "ERY-TAB" or generic name "Erythromycin"

    NDCBrand NameGeneric Name
    21695-457ERY-TABerythromycin
    24338-122ERY-TABErythromycin
    24338-124ERY-TABErythromycin
    68151-1170ERY-TABERY-TAB
    68151-1174ERY-TABERY-TAB
    24338-126ERY-TABERY-TAB
    43063-569ERY-TABERY-TAB
    50090-0339ERY-TABERY-TAB
    55289-217ERY-TABERY-TAB
    55289-525ERY-TABERY-TAB
    0378-8075ERYGELerythromycin
    0093-5571ErythromycinErythromycin
    0093-5572ErythromycinErythromycin
    0168-0215Erythromycinerythromycin
    0168-0216Erythromycinerythromycin
    0378-8212Erythromycinerythromycin
    0404-7191ErythromycinErythromycin
    0574-4024erythromycinerythromycin
    13668-586ERYTHROMYCINERYTHROMYCIN
    13668-588ERYTHROMYCINERYTHROMYCIN
    13668-606ErythromycinErythromycin
    13668-607ErythromycinErythromycin
    13985-605ErythromycinErythromycin
    17478-070ErythromycinErythromycin
    17478-824ErythromycinErythromycin
    21695-173ErythromycinErythromycin
    24208-910ErythromycinErythromycin
    24338-102ErythromycinErythromycin
    24338-104ErythromycinErythromycin
    24338-120ERYTHROMYCINErythromycin
    21695-387ERYTHROMYCIN Base FilmtabERYTHROMYCIN
    21695-389ERYTHROMYCIN Base FilmtabERYTHROMYCIN

    Trademark Results [ERY-TAB]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ERY-TAB
    ERY-TAB
    73286993 1211217 Live/Registered
    Abbott Laboratories
    1980-11-21
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.